Diatech Pharmacogenetics is a leading manufacturer in Italy specializing in the development, production, and commercialization of pharmacogenetic tests related to cancer. Established in 1996, the company has experienced steady growth over the years and now holds more than 70% of the molecular diagnostics market in Italy, with rapid expansion globally. To date, over 20,000 diagnostic tests have been conducted using its solutions, and each year, Diatech allocates 20% of its revenue to research and development (R&D).

All of Diatech’s products are developed under the EN ISO 9001 and EN ISO 13485 standards and are designed, developed, and validated in accordance with the (EU) 2017/746 regulations for diagnostic and laboratory medical devices (CE-IVD).